1.67
price down icon0.60%   -0.01
after-market After Hours: 1.65 -0.02 -1.20%
loading
180 Life Sciences Corp stock is traded at $1.67, with a volume of 16,113. It is down -0.60% in the last 24 hours and down -7.73% over the past month. 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
See More
Previous Close:
$1.68
Open:
$1.67
24h Volume:
16,113
Relative Volume:
0.03
Market Cap:
$1.71M
Revenue:
-
Net Income/Loss:
$-19.94M
P/E Ratio:
-0.0697
EPS:
-23.95
Net Cash Flow:
$-10.92M
1W Performance:
-10.22%
1M Performance:
-7.73%
6M Performance:
-28.33%
1Y Performance:
-85.65%
1-Day Range:
Value
$1.65
$1.77
1-Week Range:
Value
$1.65
$1.945
52-Week Range:
Value
$1.31
$12.02

180 Life Sciences Corp Stock (ATNF) Company Profile

Name
Name
180 Life Sciences Corp
Name
Phone
650-507-0669
Name
Address
3000 EL CAMINO REAL, PALO ALTO
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ATNF's Discussions on Twitter

180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-15-21 Initiated Maxim Group Buy

180 Life Sciences Corp Stock (ATNF) Latest News

pulisher
06:42 AM

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN

06:42 AM
pulisher
Sep 28, 2024

Amalgamated Bank Increases Stake in Atlantic Union Bankshares Co. (NASDAQ:AUB) - Defense World

Sep 28, 2024
pulisher
Sep 25, 2024

Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace

Sep 25, 2024
pulisher
Sep 24, 2024

What Goldman Sachs’s 2,600 interns think about AI - Fortune

Sep 24, 2024
pulisher
Sep 21, 2024

ChromaDex appoints new CFO Ozan Pamir - Investing.com

Sep 21, 2024
pulisher
Sep 21, 2024

ChromaDex appoints new CFO Ozan Pamir - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

ChromaDex Appoints Ozan Pamir As Chief Financial Officer - citybiz

Sep 20, 2024
pulisher
Sep 20, 2024

ChromaDex Appoints Ozan Pamir as Chief Financial Officer - Business Wire

Sep 20, 2024
pulisher
Sep 19, 2024

Life Time Group Holdings Inc [LTH] Member of 10% Owner Group makes an insider sale of 650,000 shares worth 13,572,000. – Knox Daily - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Review: ANTICHRIST - FANGORIA

Sep 19, 2024
pulisher
Sep 19, 2024

Herbalife Ltd. (NYSE:HLF) Sees Large Decline in Short Interest - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

360 One WAM board approves fundraise of worth Rs 2,250 crore via QIP - Moneycontrol

Sep 19, 2024
pulisher
Sep 19, 2024

360 ONE WAM boards OKs raising funds up to Rs 2,250 crore via QIP route - Business Standard

Sep 19, 2024
pulisher
Sep 18, 2024

InnovAge (NASDAQ:INNV) Trading Up 4.2% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Hamilton Lane (NASDAQ:HLNE) Hits New 1-Year High at $162.25 - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Hippo Holdings Inc. (NYSE:HIPO) Short Interest Update - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Quantum Blockchain Technologies (LON:QBT) Trading 10.5% Higher - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Bloomin’ Brands (NASDAQ:BLMN) Trading Down 3.2% - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Life360 Set to Join Russell 2000® and 3000® Indexes - The Tech Outlook

Sep 17, 2024
pulisher
Sep 17, 2024

Deeper Dive: Understanding Herbalife Ltd (HLF) Through its Various Ratios - The Dwinnex

Sep 17, 2024
pulisher
Sep 16, 2024

Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio Stock Skyrockets 641% in One Week: Here's Why - Yahoo Finance

Sep 16, 2024
pulisher
Sep 16, 2024

Instil Bio price target raised to $120 from $40 at H.C. Wainwright - TipRanks

Sep 16, 2024
pulisher
Sep 14, 2024

Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise

Sep 14, 2024
pulisher
Sep 14, 2024

Key Milestone in India’s Clinical Research Ecosystem: ICMR To Begin First-In-Human Clinical Trials for 4 Promising Molecules - IndianWeb2.com

Sep 14, 2024
pulisher
Sep 14, 2024

Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - AOL

Sep 14, 2024
pulisher
Sep 13, 2024

Egle names Detheux chairman - BioCentury

Sep 13, 2024
pulisher
Sep 13, 2024

Illinois Tool Works Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 13, 2024
pulisher
Sep 13, 2024

Financial Fitness Check: Examining Herbalife Ltd (HLF)’s Key Ratios - The Dwinnex

Sep 13, 2024
pulisher
Sep 12, 2024

180 Life Sciences Announces CFO Resignation and New Board Appointments - TipRanks

Sep 12, 2024
pulisher
Sep 12, 2024

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer - ForexTV.com

Sep 12, 2024
pulisher
Sep 12, 2024

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer Seite 112.09.2024 - wallstreet:online

Sep 12, 2024
pulisher
Sep 12, 2024

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer - StockTitan

Sep 12, 2024
pulisher
Sep 09, 2024

180 Life Sciences Corp. finalizes separation with former executive - Investing.com

Sep 09, 2024
pulisher
Sep 08, 2024

United States shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN

Sep 08, 2024
pulisher
Sep 05, 2024

ATNF’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Sep 05, 2024
pulisher
Sep 05, 2024

Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 05, 2024
pulisher
Sep 04, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - Mitrade

Sep 04, 2024
pulisher
Sep 03, 2024

Spark Therapeutics CEO departs to lead another life sciences company - The Business Journals

Sep 03, 2024
pulisher
Sep 02, 2024

Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Sep 02, 2024
pulisher
Aug 28, 2024

Zydus Lifesciences Shares Surge 4% on USFDA Final Approval - EquityPandit

Aug 28, 2024
pulisher
Aug 28, 2024

Assenagon Asset Management S.A. Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Aug 28, 2024
pulisher
Aug 27, 2024

180 Life Sciences (NASDAQ:ATNF) Stock Quotes, Forecast and News Summary - Benzinga

Aug 27, 2024
pulisher
Aug 19, 2024

NIH grants funds to Boston Immune’s Phase I trial of TNFR2 antagonist - Clinical Trials Arena

Aug 19, 2024
pulisher
Aug 18, 2024

ATNF (180 Life Sciences) 3-Year EPS without NRI Growth Rate : 41.70% (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

HTGMQ (HTG Molecular Diagnostics) Float Percentage Of Total Shares Outstanding : 99.92% (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

Baker Tilly Wealth Management LLC Has $236,000 Holdings in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Aug 18, 2024
pulisher
Aug 17, 2024

ATNF (180 Life Sciences) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

Q3 2024 EPS Estimates for Edwards Lifesciences Co. (NYSE:EW) Decreased by Zacks Research - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

SELLAS Life Sciences Group (NASDAQ:SLS) Issues Quarterly Earnings Results - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Kezar Life Sciences, Inc. (NASDAQ:KZR) to Post Q3 2024 Earnings of ($0.30) Per Share, William Blair Forecasts - Defense World

Aug 16, 2024

180 Life Sciences Corp Stock (ATNF) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):